Exhibit,Appendix: Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10

• 
• 
• 
• 

						
                                
Preview
                                FILED: NEW YORK COUNTY CLERK 02/01/2023 07:50 PM           INDEX NO. 652343/2018
NYSCEF DOC. NO. 760                                 RECEIVED NYSCEF: 02/01/2023




                           EXHIBIT 15
                Letter from DOH Rejecting Proposed
                Merger, Dated September 25, 2018




                                               Index No. 652343/2018
FILED: NEW YORK COUNTY CLERK 02/01/2023 07:50 PM                                             INDEX NO. 652343/2018
NYSCEF DOC. NO. 760                                                                   RECEIVED NYSCEF: 02/01/2023




                                                      September 25, 2018

          VIA CERTIFIED AND ELECTRONIC MAIL to eric@fpnys.com

          Eric Sirota
          Co-Chief Executive Officer
          Fiorello Pharmaceuticals
          12 East 49th Street, 11th Floor
          New York, New York 10017

          Dear Mr. Sirota:

                This is in response to your correspondence to me dated August 31, September 4 and
          September 5, 2018, seeking to amend Fiorello’s submission for a change in ownership and
          change the Department’s position as expressed in my letter to you dated August 23, 2018.

                  Pursuant to 10 NYCRR § 1004.8, the registration issued to Fiorello is non-transferrable.
          The Department has reviewed your amended request and hereby denies the proposed change
          in ownership, as it would still constitute a direct transfer of the registration. Among other
          reasons, Fiorello has no satisfactory tangible operational assets to sell to Green Thumb
          Industries (GTI), except its registration, which is prohibited pursuant to 10 NYCRR § 1004.8.

                 .

                                                      Sincerely,




                                                      Nicole K. Quackenbush, Pharm.D.
                                                      Director
                                                      Medical Marijuana Program